Literature DB >> 7017450

Effect of a new thienodiazepine (We-941) on sleep patterns of normal and insomniac subjects.

M Velasco, F Velasco, C Cepeda, R Romo, M A Pérez-Toledo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7017450     DOI: 10.1016/0028-3908(81)90178-7

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


× No keyword cloud information.
  7 in total

1.  Comparative study on the efficacy of and the tolerance to the triazolodiazepines, triazolam and brotizolam.

Authors:  E Goetzke; P Findeisen; I B Welbers
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

2.  Pharmacokinetics of brotizolam in the elderly.

Authors:  R Jochemsen; K L Nandi; D Corless; J G Wesselman; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

3.  Discriminative and reinforcing effects of brotizolam in rhesus monkeys.

Authors:  M A Nader; G Winger; J H Woods; W L Woolverton
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Effects of quazepam as a preoperative night hypnotic: comparison with brotizolam.

Authors:  Tomoki Nishiyama; Koichi Yamashita; Takeshi Yokoyama; Akinobu Imoto; Masanobu Manabe
Journal:  J Anesth       Date:  2007-01-30       Impact factor: 2.078

5.  Effects of brotizolam, flurazepam and placebo upon nocturnal auditory arousal thresholds.

Authors:  K M Hartse; J I Thornby; I Karacan; R L Williams
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

6.  Brotizolam and chronic insomnia: a multi-centre study.

Authors:  A Fritz-Osner; J L Arias-Ortiz; J F Dorantes; J Rabago-Sánchez; A Rodríguez-Tenorio; J Sánchez-Martinez
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

Review 7.  Brotizolam. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an hypnotic.

Authors:  M S Langley; S P Clissold
Journal:  Drugs       Date:  1988-02       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.